PA
MED icon

Profund Advisors’s Medifast MED Stock Holding History

Profund Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,066
Closed -$223K – 1385
2021
Q4 		$223K Sell
1,066
-65
-6% -$13.4K 0.01% 1221
2021
Q3 		$218K Sell
1,131
-147
-12% -$36.1K 0.01% 1201
2021
Q2 		$362K Buy
1,278
+47
+4% +$12.7K 0.01% 908
2021
Q1 		$261K Sell
1,231
-142
-10% -$34K 0.01% 1090
2020
Q4 		$270K Buy
+1,373
New +$243K 0.01% 894
2018
Q4 		– Sell
-1,803
Closed -$399K – 1313
2018
Q3 		$399K Sell
1,803
-303
-14% -$61.4K 0.02% 975
2018
Q2 		$337K Buy
+2,106
New +$269K 0.01% 1082

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Profund Advisors's MED Position: Q1 2022 in Review

Profund Advisors sold out of Medifast (MED) in Q1 2022, closing a stake of 1,066 shares — an estimated $223K sold.

Profund Advisors first reported a position in MED in Q2 2018 and held it in 7 quarters. The position peaked at $399K in Q3 2018. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Profund Advisors reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Profund Advisors sold 1,066 Medifast shares in Q1 2022, an estimated $223K.
  • Profund Advisors first reported a position in Medifast in Q2 2018 and held it in 7 quarters.
  • Profund Advisors's Medifast position peaked at $399K in Q3 2018.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Profund Advisors's 13F filing for Q1 2022, filed 10 May 2022.